Freestone Capital Holdings’s Elevance Health ELV Stock Holding History

Freestone Capital Holdings’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-761	Closed	-$223K	–	651
2026 Q1	$223K	Buy	761 +7	+0.9%	+$2.3K	0.01%	500
2025 Q4	$264K	Buy	754 +3	+0.4%	+$1.01K	0.01%	454
2025 Q3	$243K	Sell	751 -392	-34%	-$122K	0.01%	466
2025 Q2	$445K	Buy	+1,143	New	+$460K	0.02%	310
2022 Q2	–	Sell	-722	Closed	-$355K	–	480
2022 Q1	$355K	Buy	722 +185	+34%	+$84.6K	0.01%	432
2021 Q4	$249K	Buy	+537	New	+$226K	0.01%	433
2021 Q1	–	Sell	-166	Closed	-$53.3K	–	599
2020 Q4	$53.3K	Buy	+166	New	+$50.9K	﹤0.01%	555
2013 Q3	–	Sell	-15,900	Closed	-$1.3M	–	371
2013 Q2	$1.3M	Buy	+15,900	New	+$1.19M	0.27%	54

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Freestone Capital Holdings's ELV Position: Q2 2026 in Review

Freestone Capital Holdings sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 761 shares — an estimated $223K sold.

Freestone Capital Holdings first reported a position in ELV in Q2 2013 and held it in 8 quarters. The position peaked at $1.3M in Q2 2013. 927 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Freestone Capital Holdings reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Freestone Capital Holdings sold 761 Elevance Health shares in Q2 2026, an estimated $223K.
Freestone Capital Holdings first reported a position in Elevance Health in Q2 2013 and held it in 8 quarters.
Freestone Capital Holdings's Elevance Health position peaked at $1.3M in Q2 2013.
927 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.